2022. Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine. Clinics. 77, (Feb. 2022), 100007. DOI:https://doi.org/10.1016/j.clinsp.2022.100007.